Images List Premium Download Classic

Infectious

Infectious-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Devices, systems and methods to detect viable infectious agents in a fluid sample and susceptibility ...
Avails Medical, Inc.
November 30, 2017 - N°20170342459

Various devices, systems and methods for detecting infectious agents or determining a susceptibility of an infectious agent to an anti-infective are described herein. One example method comprises introducing a fluid sample to a surface; exposing the surface to a solution; sampling the solution after exposing the solution to the surface; and detecting a change in an electrical characteristic of a ...
Bandages for supplying ozone therapy
Umm-al-qura University
November 30, 2017 - N°20170340870

The present disclosure relates to a bandage wherein the bandage comprise of a first layer of protective covering, wherein the first layer is removable; a second layer of covering, wherein the second layer of covering is made of a cloth material; a third layer of covering, wherein the third layer is the top most layer of the bandage and together ...
Multiplex immuno screening assay
Institut Pasteur
November 23, 2017 - N°20170336412

The present invention provides kits and assay methods for the early detection of pathogens, precise identification of the etiologic agent, and improved disease surveillance. More specifically, the present invention discloses an immunoassay leading to the rapid and simultaneous detection of antibodies to a wide range of infectious pathogens in biological fluids of infected patients. This immunoassay involves the covalent and ...
Infectious Patent Pack
Download 268+ patent application PDFs
Infectious Patent Applications
Download 268+ Infectious-related PDFs
For professional research & prior art discovery
inventor
  • 268+ full patent PDF documents of Infectious-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Methods and compositions for the activation of gamma-delta t-cells
American Gene Technologies International Inc.
November 23, 2017 - N°20170335344

The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta t-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.
Nitroimidazole compound, preparation method therefor and use thereof in drug manufacturing
Shanghai Sun-sail Pharmaceutical Science & Technology Co., Ltd.
November 23, 2017 - N°20170334927

A nitroimidazole compound represented by general formula (i) or an optical isomer thereof or a pharmaceutically acceptable salt thereof, and a preparation method therefore, and use thereof in manufacturing drugs for the treating infectious diseases caused by mycobacterium tuberculosis. Specific groups in general formula (i) are as defined in the specification.
Novel mitochondrial uncouplers for treatment of metabolic diseases and cancer
Shanghai Sun-sail Pharmaceutical Science & Technology Co., Ltd.
November 23, 2017 - N°20170334869

The present disclosure relates to benzamide compounds, prodrugs of the compounds, pharmaceutical compositions containing the compounds and/or the prodrugs and methods of using the compounds, prodrugs and pharmaceutical compositions in the treatment of diseases related to lipid metabolism including diabetes, non-alcholic fatty liver disease (nafld), non-alcholic steathohepatitis (nash), diseases caused by abnormal cell proliferation including cancer, psoriasis, and infectious ...
Infectious Patent Pack
Download 268+ patent application PDFs
Infectious Patent Applications
Download 268+ Infectious-related PDFs
For professional research & prior art discovery
inventor
  • 268+ full patent PDF documents of Infectious-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Dosage and administration of non-fucosylated anti-cd40 antibodies
Seattle Genetics, Inc.
November 23, 2017 - N°20170333556

This invention relates methods of using a non-fucosylated anti-cd40 antibody for treatment of cancer and chronic infectious diseases.
Convergent and enantioselective total synthesis of communesin analogs
Seattle Genetics, Inc.
November 23, 2017 - N°20170333405

Or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein r1-r8 and m, n, r, s, t, and u are as defined herein, is provided. Methods of making such compounds are also disclosed as are methods for the treatment of cancer, various infectious diseases, and abnormal cardiovascular function.
Method for making ice cream
Ali S.p.a. - Carpigiani Group
November 23, 2017 - N°20170332659

A method for making ice cream including the following steps, performed in the following order: heating the side walls of the processing container to a preset preheating temperature; placing a basic ice cream mixture in the processing chamber after the step of heating the side walls of the processing container to a preset preheating temperature; deactivating any infectious agents which ...
Recombinant viral vectors
International Aids Vaccine Initiative
November 16, 2017 - N°20170327544

The present relation relates to recombinant vesicular stomatitis virus for use as prophylactic and therapeutic vaccines for infectious diseases of aids. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.
Compositions and methods for the treatment of mucositis
Cellix Bio Private Limited
November 16, 2017 - N°20170327482

The invention relates to the compounds of formula i, formula ii, formula iii, formula iv, formula v, formula vi, formula vii and formula viii, or its pharmaceutical acceptable polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula i, formula ii, formula iii, formula iv, formula v, formula vi, formula vii and ...
Dosage regimen for pegylated interferon
Pharmaessentia Corporation
November 16, 2017 - N°20170326206

A pegylated type i interferon for use in treating an infectious disease, cancer, or myeloproliferative disease in a subject in need thereof, wherein a 50 to 540 μg dose of the pegylated type i interferon is administered to the subject at a regular interval for a treatment period, the interval being 3 to 8 weeks.
Method of preparing mirabilitum praeparatum by pure strain fermentation and its applications
Pharmaessentia Corporation
November 16, 2017 - N°20170326187

The present invention involves a method of preparing mirabilitum praeparatum by pure strain fermentation and its application in treating infectious and inflammatory diseases, as well as health products and cosmetics. The method involves blending the ripe fruit (watermelon) of citrullus lanatus (thumb.) matsumu. Et nakai with mirabilite (na2so4. 10h2o) according to a certain ratio as culture media and ...
Infectious Patent Pack
Download 268+ patent application PDFs
Infectious Patent Applications
Download 268+ Infectious-related PDFs
For professional research & prior art discovery
inventor
  • 268+ full patent PDF documents of Infectious-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Cai-based systems and methods for the localized treatment of uveitis
Gen Pharma Holdings, Llc
November 09, 2017 - N°20170319550

This invention relates to the treatment of uveitis, in particular posterior infectious uveitis. In specific embodiments, the invention provides for methods of treating uveitis and/or infectious uveitis comprising administration of a sustained-release system containing 5-amino-[4-(4-chlorobenzoyl)-3,5-dichlorobenzyl]-1,2,3-triazole-4-carboxamide) and optionally a glucocorticoid. In one embodiment, the glucocorticoid is dexamethasone. In another embodiment, the sustained-release system ...
Icos binding proteins
Gen Pharma Holdings, Llc
November 02, 2017 - N°20170313777

The present invention relates to an icos binding protein or antigen binding portion thereof that is an agonist to human icos and does not induce complement, adcc, or cdc when placed in contact with a t cell in vivo and methods of treating cancer, infectious disease and/or sepsis with said icos binding protein or antigen binding portion thereof. Further ...
Compositions and methods related to viral vaccines
Gen Pharma Holdings, Llc
November 02, 2017 - N°20170313763

Provided herein are methods and compositions relating to infectious bursal disease virus (ibdv), and vaccines for treatment and prevention thereof.
Pyrazolo[1,5-a]pyridine compounds and use thereof
Gen Pharma Holdings, Llc
November 02, 2017 - N°20170313697

Disclosed in the disclosure are a pyrazolo[1,5-a]pyrideine compound with structural features as shown in formula (i) or a pharmaceutically acceptable salt, stereoisomer or prodrug molecule thereof and a use thereof. Such compounds have a good in vitro antituberculosis activity, and the minimal inhibitory concentration (mic) of the compounds is lower than 0. 1 μg/ml and partially achieves 0. 01 &#...
Compositions and methods to prevent and treat biofilms
Gen Pharma Holdings, Llc
November 02, 2017 - N°20170312345

Compositions and methods to treat biofilms are disclosed based on the discovery of the role of the disaccharide trehalose in microbial biofilm development. In various embodiments to treat body-borne biofilms systemically and locally, the method includes administering trehalase, the enzyme which degrades trehalose, in combination with other saccharidases for an exposition time sufficient to adequately degrade the biofilm gel matrix ...
Targeted conjugates and particles and formulations thereof
Gen Pharma Holdings, Llc
November 02, 2017 - N°20170312245

Nanoparticles and microparticles, and pharmaceutical formulations thereof, containing conjugates of an active agent such as a therapeutic, prophylactic, or diagnostic agent attached to a targeting moiety, such as a somatostatin receptor binding moiety, via a linker have been designed. Such nanoparticles and microparticles can provide improved temporospatial delivery of the active agent and/or improved biodistribution. Methods of making the ...
Monitoring method, information processing apparatus, information processing system, and non-transitory computer readable medium
Sysmex Corporation
October 26, 2017 - N°20170309148

The present invention provides a monitoring method for infectious diseases. The monitoring method includes: obtaining disease information from a plurality of medical facilities 131, 132, 133, and 134; determining the disease occurrence status for each medical facility based on the disease information and a first criterion related to the disease occurrence status at the medical facility; and generating first area alarm information related to ...
Compositions and methods of use for augmented immune response and cancer therapy
Sysmex Corporation
October 26, 2017 - N°20170306038

The present invention provides antibody compositions, including, e. G., antibodies, engineered antibodies and antibody fragments that bind to a tumor necrosis factor receptor superfamily member (i. E., 18), and compositions comprising one or more additional therapeutic agents. Provided compositions are useful in enhancing cd4+ and cd8+ t cell responses, and in the treatment, amelioration and prevention of diseases that can be ...
Loading